Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonionic monomers and dimers

F Stacul1, H S Thomsen

  • 1Department of Radiology, University Hospital of Trieste, Ospedale di Cattinara, Italy.

European Radiology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.

Scandinavian journal of rheumatology·2021
Same author

Ultrasound-guided electrochemotherapy for the treatment of skin metastases of breast cancer: a winning combination of techniques.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

<sup>1</sup>H-MRS measured ectopic fat in liver and muscle is associated with the metabolic syndrome in Danish girls but not in boys with overweight and obesity.

Obesity science & practice·2017
Same author

Radiofrequency ablation for benign thyroid nodules.

Journal of endocrinological investigation·2016
Same author

Clinical application of low-dose phase contrast breast CT: methods for the optimization of the reconstruction workflow.

Biomedical optics express·2015
Same author

Liver fat content investigated by magnetic resonance spectroscopy in obese children and youths included in multidisciplinary treatment.

Clinical obesity·2015
Same journal

ESR Essentials: pelvic floor imaging-practice recommendations by the European Society of Urogenital Radiology.

European radiology·2026
Same journal

STIR or T2-Dixon? A false dilemma in musculoskeletal MRI.

European radiology·2026
Same journal

ESR Essentials: uterine cancers-practice recommendations by the European Society of Urogenital Radiology.

European radiology·2026
Same journal

Adjunctive quantification for more reproducible amyloid PET interpretation.

European radiology·2026
Same journal

APEX-NET: automated pancreatic evaluation network using early non-contrast CT.

European radiology·2026
Same journal

Temporal bone remodeling after venous stenting for pulsatile tinnitus: isolated dehiscence versus diverticulum.

European radiology·2026
See all related articles

The debate on contrast media is over, with newer nonionic agents showing minimal clinical differences. Further research is needed to determine if significant variations exist between these contrast agents.

Area of Science:

  • Radiology
  • Medical Imaging
  • Pharmacology

Background:

  • The historical debate centered on high-osmolar ionic versus low-osmolar nonionic contrast media.
  • Current focus shifts to differentiating between various nonionic contrast agents.

Purpose of the Study:

  • To evaluate the clinical significance of differences among multiple nonionic contrast agents.
  • To compare new nonionic monomers and dimers with previous contrast media.

Main Methods:

  • Review of clinical practice and outcomes related to different nonionic contrast media.
  • Comparison of observed clinical differences with manufacturer claims.

Main Results:

  • Manufacturers claim differences exist among the ten available nonionic contrast agents (eight monomers, two dimers).

Related Experiment Videos

  • Clinical practice reveals only marginal differences between these agents, unlike the stark contrast seen with older media.

    • Conclusions:

    • The clinical importance of differences between the new nonionic contrast agents remains uncertain.
    • Long-term observation is required to ascertain any major clinical distinctions between existing and novel nonionic agents.